Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Zhuochao, Liu"'
Autor:
Meng Li, Qiyuan Bao, Zhusheng Zhang, Beichen Wang, Zhuochao Liu, Junxiang Wen, Rong Wan, Yuhui Shen, Weibin Zhang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Recent clinical trials have demonstrated a lack of activity of immune checkpoint inhibitors (ICIs) against osteosarcoma. Previous clinical observations have demonstrated a potential immune-stimulatory effect of tumor site infection for osteosarcoma p
Externí odkaz:
https://doaj.org/article/490c00b896d54facaaf506359ee648d1
Autor:
Yucheng Fu, Zhijian Jin, Yuhui Shen, Zhusheng Zhang, Meng Li, Zhuochao Liu, Guoyu He, Jintao Wu, Junxiang Wen, Qiyuan Bao, Jun Wang, Weibin Zhang
Publikováno v:
Translational Oncology, Vol 22, Iss , Pp 101452- (2022)
Background: Apoptosis played vital roles in the formation and progression of osteosarcoma. However, no studies elucidated the prognostic relationships between apoptosis-associated genes (AAGs) and osteosarcoma. Methods: The differentially expressed g
Externí odkaz:
https://doaj.org/article/34f4e13f5bca47919c9c3ff573267600
Autor:
Zhuochao Liu, Hongyi Wang, Chuanzhen Hu, Chuanlong Wu, Jun Wang, Fangqiong Hu, Yucheng Fu, Junxiang Wen, Weibin Zhang
Publikováno v:
Cell Death and Disease, Vol 12, Iss 2, Pp 1-15 (2021)
Abstract In this study, we identified the multifaceted effects of atezolizumab, a specific monoclonal antibody against PD-L1, in tumor suppression except for restoring antitumor immunity, and investigated the promising ways to improve its efficacy. A
Externí odkaz:
https://doaj.org/article/db65ee44e4924deaa2fd223ce9a28d2d
Autor:
Yucheng Fu, Qi Liu, Qiyuan Bao, Junxiang Wen, Zhuochao Liu, Yuehao Hu, Guoyu He, Cheng Peng, Yiqi Xu, Weibin Zhang
Publikováno v:
Hereditas, Vol 158, Iss 1, Pp 1-14 (2021)
Abstract Background Osteosarcoma is the primary bone malignant neoplasm that often develops metastasis. Increasing evidences have shown that non-coding RNAs (ncRNAs) relate to the progression of osteosarcoma. However, the ncRNAs’ roles in osteosarc
Externí odkaz:
https://doaj.org/article/6d33506930e74286a55d65959a7557e6
Autor:
Yucheng Fu, Qiyuan Bao, Zhuochao Liu, Guoyu He, Junxiang Wen, Qi Liu, Yiqi Xu, Zhijian Jin, Weibin Zhang
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
BackgroundIncreasing evidence has shown that hypoxia microenvironment relates to tumor initiation and progression. However, no studies focus on the application of hypoxia-associated genes in predicting osteosarcoma patients’ prognosis. This researc
Externí odkaz:
https://doaj.org/article/4496de8c709b4a93bd2edc51fab24450
Autor:
Zhuochao Liu, Changwei Li, Ping Huang, Fangqiong Hu, Min Jiang, Xing Xu, Bin Li, Lianfu Deng, Tianwen Ye, Lei Guo
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Tumor necrosis factor-alpha (TNF-α) promotes osteoclasts differentiation to enhance bone resorption and inhibits osteoblasts differentiation to impair bone formation, which plays a central role in the development of postmenopausal osteoporosis (PMOP
Externí odkaz:
https://doaj.org/article/17111a09b948416bb9be9b83bf7871a0
Autor:
Zhuochao Liu, Zhiyong Zheng, Jin Qi, Jun Wang, Qi Zhou, Fangqiong Hu, Jing Liang, Changwei Li, Weibin Zhang, Xingkai Zhang
Publikováno v:
Journal of Biological Engineering, Vol 12, Iss 1, Pp 1-15 (2018)
Abstract Background Cell-based therapy by transplantation of nucleus pulposus (NP) progenitor/notochordal cells has been proposed as a promising way to halt and reverse the progression of disc degeneration. Although some studies have provided a broad
Externí odkaz:
https://doaj.org/article/2ada085b6fb2498eb7ad327a52e48b87
Autor:
Hongyi, Wang, Zhuochao, Liu, Jun, Wang, Fangqiong, Hu, Qi, Zhou, Li, Wei, Qiyuan, Bao, Jizhuang, Wang, Jing, Liang, Zhihong, Liu, Weibin, Zhang
Publikováno v:
Frontiers of Medicine. 16:883-895
Metastasis and drug resistance are the leading causes of poor prognosis in patients with osteosarcoma. Identifying the relevant factors that drive metastasis and drug resistance is the key to improving the therapeutic outcome of osteosarcoma. Here, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ebd77e28f47dd5373bd962413b53fb9
https://doi.org/10.1007/s11684-022-0919-0
https://doi.org/10.1007/s11684-022-0919-0
Publikováno v:
International Journal of Medicine Frontiers. 5:10-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb1fdf1c4e4220e2005b91525028e907
https://doi.org/10.26855/ijmf.2022.10.002
https://doi.org/10.26855/ijmf.2022.10.002
Autor:
Zhusheng Zhang, Guoyu He, Yucheng Fu, Zhijian Jin, Q. Bao, Junxiang Wen, Weibin Zhang, Jun Wang, Zhuochao Liu
Publikováno v:
Journal of Inflammation Research
Yucheng Fu, Guoyu He, Zhuochao Liu, Jun Wang, Zhusheng Zhang, Qiyuan Bao, Junxiang Wen, Zhijian Jin, Weibin Zhang Department of Orthopedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Trauma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32979d9e1ff24750c0d5239649f792c1
https://doi.org/10.2147/jir.s340477
https://doi.org/10.2147/jir.s340477